CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study

Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee

Cancer Research and Treatment. 2023;55(1):245-257. Published online 2022 July 19 DOI: https://doi.org/10.4143/crt.2022.232

Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study

Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee

Cancer Research and Treatment. 2023;55(1):245-257

Link1

Link2 Link3

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

J.T. Thigpen

Yearbook of Oncology. 2012;2012:114-115

Link1 Link2

Impact of bevacizumab and secondary cytoreductive surgery on survival outcomes in platinum-sensitive relapsed ovarian clear cell carcinoma: A multicenter study in Korea

Se Ik Kim, Ji Hyun Kim, Joseph J. Noh, Seung-Ho Kim, Tae Eun Kim, Kidong Kim, Jeong-Yeol Park, Myong Cheol Lim, Jeong-Won Lee, Jae-Weon Kim

Gynecologic Oncology. 2022;166(3):444-452

Link1 Link2

Maintenance olaparib monotherapy for platinum-sensitive relapsed ovarian cancer in patients without a germline BRCA1/BRCA2 mutation: Secondary safety results from the phase IIIb OPINION study (128)

Nicoletta Colombo, Radoslaw Madry, Erik Škof, Johanne Weberpals, Chris Blakeley, Helen Marshall, Neil Brickel, Andrés Poveda

Gynecologic Oncology. 2022;166:S81-S82

Link1 Link2

Maintenance therapy utilization in platinum-sensitive recurrent epithelial ovarian cancer: A 'real-world' analysis

H.A. Moss, L.J. Havrilesky, N.D. Kauff, A.A. Secord

Gynecologic Oncology. 2019;154:204

Link1 Link2

Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study

C. Marchetti, A. Rosati, G. Scaletta, A. Pietragalla, M. Arcieri, R. Ergasti, E. Palluzzi, G. Scambia, A. Fagotti

Gynecologic Oncology. 2019;155(3):400-405

Link1 Link2

The Role of Secondary Cytoreductive Surgery in Primary Platinum-sensitive Recurrent HGSOC Patients With Different BRCA1/2 Mutation Status: a Retrospective Study

Hualei Bu, Xia Wang, Yana Ma, Jin Peng, Shuai Feng, Mengdi Fu, Jingying Chen, Lekai Nie, Chengjuan Jin, Youzhong Zhang

. 2021;

Link1 Link2

Secondary cytoreductive surgery did not improve survival in women with advanced ovarian cancer

Evidence-based Obstetrics & Gynecology. 2005;7(3):157-159

Link1 Link2

Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china

Yamin Shu, Yanxin Liu, Xucheng He, Yufeng Ding, Qilin Zhang

Frontiers in Pharmacology. 2022;13:

Link1

Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer

Haley A. Moss, Jessica A. Perhanidis, Laura J. Havrilesky, Angeles Alvarez Secord

Gynecologic Oncology. 2021;163(1):50-56

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.